7th July 2022 | Pharma Updates

USFDA approved Aurobindo Pharma's Triamcinolone Acetonide injectable suspension

Triamcinolone Acetonide injectable suspension is suggested for a number of disorders, according to Aurobindo Pharma Ltd., whose subsidiary Eugia Pharma Specialities Ltd. has acquired final permission from the US health agency to produce and commercialise it.

India must switch from a fee-for-service to a value-based healthcare paradigm: Dr. Suman Katragadda

The value-based healthcare (VBHC) model must be adopted in India in place of the fee for-service (FFS) model. Using a fee-for-service (FFS) approach, healthcare professionals are compensated according to the quantity of services rendered.

Income Tax Department raided the Bengaluru office of Dolo-650 producer Micro Lab

The popular drug manufacturer Micro Labs Limited’s office in Bengaluru was raided by the Income Tax Department. According to sources, the raids were carried out in relation to tax evasion.

Zydus Wellness seeking for acquisitions on proactive basis

The iconic brands Glucon-D, Complan, and Nycil are owned by Ahmedabad-based consumer goods business Zydus Wellness through acquisitions. Zydus Wellness is actively seeking for inorganic development possibilities to complement its expansion goals.

BeiGene & InnoRNA announces research partnership to develop novel mRNA treatments

BeiGene announced a global strategic agreement with InnoRNA to leverage their breakthrough technological platform for the development of mRNA-based medicines.

Launch of Aurobac to combat antimicrobial resistance

A collaborative venture between Boehringer Ingelheim and bioMérieux was announced in order to develop the next generation of antibiotics as well as practical diagnostics to combat antimicrobial resistance (AMR).

Biocon Biologics' new production plant in Bengaluru received EU GMP accreditation

Biocon Biologics, a Biocon Ltd. subsidiary based in Bengaluru, has received EU Good Manufacturing Practice (GMP) accreditation for its new monoclonal antibodies (mAbs) medicinal substance manufacturing facility at Biocon Park in Bengaluru.